Upload Image (Max 20MB per Image)
Sanofi and Regeneron Pharmaceuticals have announced the commencement of patient enrollment in two Phase 3 rheumatoid arthritis (RA) trials, the COMPARE and ASCERTAIN trials, with Sarilumab. The first fully human monoclonal antibody ...
Tags: Sanofi, Regeneron, Rheumatoid Arthritis Trials